Invivyd
Price & Volume
Stats
See more52W Range | $0.35-$2.74 |
Market Cap | $330.1M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $46.2M |
Revenue Growth (YoY) | 420.6% |
Gross Profit (12 Mos) | $43.1M |
Diluted EPS | -$0.92 |
News
See moreYahoo Finance • 3 days ago
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Yahoo Finance • 12 days ago
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Yahoo Finance • last month
Invivyd Gets FDA Clearance To Start Clinical Trials For COVID-19 Antibody VYD2311
About
CFO | Mr. William E. Duke Jr., M.B.A. |
Address | 1601 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 99 |
